Wetzel Stefanie, Wollenberg Andreas
Department of Dermatology, Ludwig-Maximilians-University, Frauenlobstrasse 9-11, 80337 München, Germany.
Eur J Dermatol. 2004 Jan-Feb;14(1):73-4.
Eczema molluscatum describes the occurrence of molluscum contagiosum virus infection in a patient with underlying atopic dermatitis. Novel, safe and effective treatment options in atopic dermatitis are the topical immunomodulators tacrolimus and pimecrolimus. One major advantage over corticosteroids is that they do not induce skin atrophy. Some physicians fear that topical immunomodulators may predispose patients to skin infections. We observed a patient with atopic dermatitis who developed eczema molluscatum during treatment with tacrolimus 0.1% ointment. After withdrawal of tacrolimus, the lesions resolved spontaneously over 3 weeks.
痘疮样湿疹描述了传染性软疣病毒感染在患有特应性皮炎的患者中的发生情况。特应性皮炎的新型、安全且有效的治疗选择是外用免疫调节剂他克莫司和吡美莫司。与皮质类固醇相比，一个主要优点是它们不会引起皮肤萎缩。一些医生担心外用免疫调节剂可能使患者易患皮肤感染。我们观察到一名患有特应性皮炎的患者在使用0.1%他克莫司软膏治疗期间发生了痘疮样湿疹。停用他克莫司后，皮损在3周内自行消退。
